MBOAT2: A Potential Drug Target and Biomarker (G129642)

Target Name: MBOAT2

NCBI ID: G129642

MBOAT2

MBOAT2: A Potential Drug Target and Biomarker

MBOAT2 (lysophospholipid acyltransferase 13) is a gene that encodes a protein involved in lipid metabolism. The study of MBOAT2 and its associated diseases has gained significant attention in recent years due to its potential as a drug target and biomarker. In this article, we will discuss the biology of MBOAT2, its potential drug targets, and its potential as a biomarker for various diseases.

Biography of MBOAT2

MBOAT2 is a gene that encodes a protein with 215 amino acid residues. The protein has a unique structure that consists of a long extracellular domain, a catalytic domain, and a short cytoplasmic domain. MBOAT2 is located on chromosome 1p36 and has been identified as a gene that is involved in various cellular processes, including cell signaling, DNA replication, and metabolism.

Potential Drug Targets

MBOAT2 has been identified as a potential drug target due to its involvement in various cellular processes. The catalytic domain of MBOAT2 contains a unique catalytic site that is known to be involved in the regulation of lipid metabolism. This site has been shown to play a role in the metabolism of fatty acids, which is critical for maintaining cellular health and function.

MBOAT2 has also been shown to be involved in the regulation of cellular signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. Therefore, MBOAT2 may be a useful target for drugs that are designed to modulate these signaling pathways.

In addition to its involvement in cellular signaling, MBOAT2 has also been shown to be involved in the regulation of cellular cytoskeleton structure. The cytoskeleton is a complex structure that is involved in the regulation of cellular movement and the maintenance of cell shape. Therefore, MBOAT2 may be a useful target for drugs that are designed to modulate cytoskeleton structure and functions.

Potential Biomarkers

MBOAT2 has also been shown to be involved in the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism. Therefore, it may be a potential biomarker for various diseases. For example, MBOAT2 has been shown to be involved in the regulation of cellular signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. Therefore, MBOAT2 may be a potential biomarker for diseases that are characterized by the uncontrolled growth and proliferation of cells.

In addition to its involvement in cellular signaling, MBOAT2 has also been shown to be involved in the regulation of cellular cytoskeleton structure. The cytoskeleton is a complex structure that is involved in the regulation of cellular movement and the maintenance of cell shape. Therefore, MBOAT2 may be a potential biomarker for diseases that are characterized by the disruption of cellular structure and function.

Conclusion

MBOAT2 is a gene that encodes a protein involved in lipid metabolism and cellular signaling pathways. Its unique structure and location on chromosome 1p36 make it a potential drug target and biomarker. The study of MBOAT2 and its associated diseases has gained significant attention in recent years, and its potential as a drug target and biomarker continues to be explored.

Protein Name: Membrane Bound O-acyltransferase Domain Containing 2

Functions: Acyltransferase which catalyzes the transfert of an acyl group from an acyl-CoA to a lysophospholipid leading to the production of a phospholipid and participates in the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle (PubMed:18772128). Catalyzes preferentially the acylation of lysophosphatidylethanolamine (1-acyl-sn-glycero-3-phosphoethanolamine or LPE) and lysophosphatidic acid (LPA) and to a lesser extend lysophosphatidylcholine (LPC) and lysophosphatidylserine (LPS) (PubMed:18772128). Prefers oleoyl-CoA as the acyl donor (PubMed:18772128). May be involved in chondrocyte differentiation (By similarity)

The "MBOAT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MBOAT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets